Loading patent…
OwnerDavid SONGinventor
Estimating the term…
The present invention relates to a pharmaceutical composition for preventing or treating cancer, comprising a recombinant stabilized galectin-9 protein, and it was confirmed that as a result of treating cancer cells with the recombinant stabilized galectin-9 protein, the effects of inhibiting the cell growth of the cancer cells and inducing cell death were exhibited; as a result of administering the recombinant stabilized galectin-9 protein to a cancer-induced animal model, the effects of reducing the size of cancer tissue and increasing viability without side effects such as weight loss were exhibited; and, when a complex, mixture or combination of the protein and an anticancer drug is administered, synergistic anticancer activity was exhibited, and thus the pharmaceutical composition comprising a recombinant stabilized galectin-9 protein as an active ingredient, according to the present invention, can be effectively used for prevention or treatment of cancer.
A method of treating cancer, the method comprising administering to a subject a pharmaceutically effective amount of a recombinant stabilized galectin-9 protein having an amino acid sequence represented by SEQ ID NO:
A method of treating cancer, the method comprising administering to a subject a formulation comprising a pharmaceutically effective amount of a recombinant stabilized galectin-9 protein having an amino acid sequence represented by SEQ ID NO:
(canceled)
(canceled)
(canceled)
A method of preventing cancer comprising administering to a subject a pharmaceutically effective amount of a recombinant stabilized galectin-9 protein having an amino acid sequence represented by SEQ ID NO:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.